Subjective but not objective numeracy influences willingness to pay for BRCA1/2 genetic testing

A positive test result for BRCA1/2 gene mutation is a substantial risk factor for breast and ovarian cancer. However, testing is not always covered by insurance, even for high risk women. Variables affecting willingness to pay (WTP) have implications for clinic-based and direct-to-consumer testing....

Full description

Bibliographic Details
Main Authors: Talya Miron-Shatz, Yaniv Hanoch, Glen M. Doniger, Zehra B. Omer, Elissa M. Ozanne
Format: Article
Language:English
Published: Cambridge University Press 2014-03-01
Series:Judgment and Decision Making
Subjects:
Online Access:http://journal.sjdm.org/13/131116/jdm131116a.pdf